These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cefmenoxime pharmacokinetics in patients with renal insufficiency. Polk RE, Sica DA, Kerkering TM, Kline BJ, Patterson PM, Baggett JW. Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis. Konishi K. Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882 [Abstract] [Full Text] [Related]
8. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. Granneman GR, Sennello LT, Steinberg FJ, Sonders RC. Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of cefepime in subjects with renal insufficiency. Barbhaiya RH, Knupp CA, Forgue ST, Matzke GR, Guay DR, Pittman KA. Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125 [Abstract] [Full Text] [Related]
10. Effect of probenecid on the pharmacokinetics of cefmenoxime. Sennello LT, Quinn D, Rollins DE, Tolman KG, Sonders RC. Antimicrob Agents Chemother; 1983 Jun; 23(6):803-7. PubMed ID: 6311084 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. Rouan MC, Binswanger U, Bammatter F, Theobald W, Schoeller JP, Guibert J. J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464 [Abstract] [Full Text] [Related]
12. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g]. Veyssier P, Bryskier A, Modai J, Boquet A, Fourtillan JB. Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis. Konishi K, Ozawa Y. Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats. Kita Y, Itakura K, Tsuchiya K, Imada A. J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784 [Abstract] [Full Text] [Related]
18. Elimination kinetics of ceftizoxime in humans with and without renal insufficiency. Ohkawa M, Okasho A, Sugata T, Kuroda K. Antimicrob Agents Chemother; 1982 Aug; 22(2):308-11. PubMed ID: 6100425 [Abstract] [Full Text] [Related]
19. Relationship between renal function and disposition of oral cefixime. Dhib M, Moulin B, Leroy A, Hameau B, Godin M, Johannides R, Fillastre JP. Eur J Clin Pharmacol; 1991 Aug; 41(6):579-83. PubMed ID: 1815970 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency. Guay DR, Meatherall RC, Harding GK, Brown GR. Antimicrob Agents Chemother; 1986 Sep; 30(3):485-90. PubMed ID: 3777912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]